Palatin Technologies
PTN
#9822
Rank
A$70.53 M
Marketcap
A$41.42
Share price
28.62%
Change (1 day)
2,830.54%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$26.32 Million

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$40.58 Million, an increase over its 2023 earnings that were of -A$48.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$26.32 Million-35.15%
2024 -A$40.58 Million-16.9%
2023 -A$48.83 Million5.99%
2022 -A$46.08 Million-13.7%
2021 -A$53.39 Million33.25%
2020 -A$40.07 Million-172.11%
2019 A$55.55 M2352.33%
2018 A$2.26 M-94.13%
2017 A$38.6 M-154.92%
2016 -A$70.29 Million3.67%
2015 -A$67.81 Million878%
2014 -A$6.94 Million-72.64%
2013 -A$25.34 Million-33.11%
2012 -A$37.88 Million77.71%
2011 -A$21.32 Million
2003 -A$36.1 Million29.93%
2002 -A$27.78 Million36.18%
2001 -A$20.4 Million
1999 -A$16.94 Million6.04%
1998 -A$15.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-A$17.79 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$44.42 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.87 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$76.14 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.10 B-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.79 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$83.68 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.71 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK